Anti-infective therapies encompass a diverse array of treatments designed to combat microbial infections and improve patient outcomes. Antibiotics, a cornerstone of these therapies, target bacterial infections through various mechanisms, disrupting bacterial cell walls or inhibiting protein synthesis. Antiviral medications are vital in managing viral infections, with drugs like acyclovir and ritonavir inhibiting the replication of viruses such as herpes and HIV. Antifungal agents like amphotericin B address fungal infections, crucial in scenarios like systemic candidiasis. Combating emerging infectious diseases often requires a multifaceted approach. Vaccines, a proactive form of anti-infective therapy, stimulate the immune system to recognize and neutralize pathogens, preventing infections. Additionally, advancements in immunomodulatory drugs contribute to enhancing the body's natural defense mechanisms against infections. As the landscape of infectious diseases evolves, ongoing research strives to develop innovative anti-infective therapies, emphasizing the importance of a dynamic and adaptable approach to disease management.
Title : The role of the humoral innate immune system in evasion of streptococcus pyogenes infections
Francis J. Castellino, University of Notre Dame, United States
Title : Global environmental changes and mosquito-borne diseases in coastal areas
Ranjan Ramasamy, IDFISH Technology, United States
Title : The impact of global antibiotic resistance on the healthcare system, public health, environment and society
Reza Nassiri, Michigan State University, United States
Title : Current topics of adult COVID-19, Influenza, and RS virus patients in Japan
Seki Masafumi, Saitama Medical University International Medical Center, Japan
Title : Novel nanotechnology and its potential applications
Stephen Hsu, Augusta University, United States
Title : 2000 years of pandemics: Past, present and future
Claudia Ferreira, Biophytis Sorbonne, France